Ribociclib + Mao Inhibitors Interaction
Majorinteraction on record
Description
Strong CYP3A inhibitors increase ribociclib exposure, which may increase incidence and severity of adverse reactions including QTcF prolongation. Avoid concomitant use or reduce KISQALI dose.
Mechanism
CYP3A inhibition increases ribociclib plasma concentrations
Source: NLP:ribociclib